• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There aren't many studies regarding how exposure over time may affect a fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological disorders such as hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against the potential risks to the fetus. Doctors don't have enough data to provide clear recommendations, but can provide information on the risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers used a large sample-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct classification of the cases and to reduce the chance of bias.

The study of the researchers had some limitations. In particular, they were not able to differentiate the effects of the medication from the effects of the disorder at hand. This limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. Researchers also did not examine long-term outcomes for the offspring.

The study did find that babies whose mothers had taken ADHD medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean section or having a child with low Apgar score (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the greater benefits for both mother and child of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies for improving their coping skills that may minimize the effects of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made in the absence of clear and authoritative evidence in either case, which means that doctors have to weigh their experience, the experiences of other doctors, and what the research suggests about the subject as well as their own judgments for each individual patient.

Particularly, the issue of potential risks to the baby can be a challenge. Many of the studies on this issue are based on observational evidence rather than controlled research and their conclusions are often contradictory. Most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these limitations by analyzing data on live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects, other studies have not found a correlation. most Popular adhd medication; telegra.ph, studies have shown that there is a neutral, or somewhat negative, impact. Therefore, a careful risk/benefit assessment is required in every situation.

It can be challenging, if not impossible for women suffering from ADHD to stop taking their medication. In an article published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for patients with ADHD. In addition, a decrease in medication can interfere with the ability to complete work-related tasks and safely drive that are crucial aspects of a normal life for a lot of people with ADHD.

She recommends women who are unsure about whether or not to stop taking medication because of their pregnancy should consider educating family members, friends and colleagues on the condition, its impact on daily functioning, and the advantages of staying on the current treatment regimen. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can be passed through the placenta. If a woman decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the drug may be transferred to her baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. With two massive data sets researchers were able to analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD medication use was associated with slightly higher rates of specific heart defects such as ventriculoseptal defect.

The researchers behind the study found no link between early use of medication and congenital abnormalities such as facial clefting or club foot. The results are in line with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter half of pregnancy when many women decided to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely to need a caesarean and also have a low Apgar after delivery and had a baby that required breathing assistance at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who did not have any other medical issues that could have contributed to these findings.

The researchers hope that their research will serve to inform the clinical decisions of physicians who see pregnant women. The researchers suggest that while discussing risks and benefits are crucial, the decision on whether to continue or stop medication should be based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that, while stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health problems in women who are pregnant or post-partum. Additionally, the research suggests that women who decide to stop taking their medication are more likely to experience a difficult time getting used to life without them following the baby's arrival.

Nursing

The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments and making preparations for the arrival of their child and getting used to new routines at home may face a lot of challenges. This is why many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs pass through breast milk in small quantities, so the risk for infant who is breastfeeding is low. However, the rate of medication exposure to the infant can a doctor prescribe adhd medication without a diagnosis differ based on dosage, frequency it is administered, and at what time it is administered. In addition, various drugs enter the infant's system through the gastrointestinal tract, or through breast milk. The effect on a newborn's health is not completely known.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant medication during the pregnancy of a woman. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the potential dangers to the embryo. In the meantime, until more information is available, GPs may inquire about pregnant patients whether they have a background of ADHD or if they plan to take medication in the perinatal phase.

Numerous studies have proven that women can continue taking their ADHD medication safely during pregnancy and while breast-feeding. In response, a rising number of patients are opting to do so. They have discovered after consulting with their doctor, that the benefits of continuing their current medication far outweigh any possible risks.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD be aware of their symptoms and underlying disorder Learn about the available treatments and to reinforce existing strategies for managing. This should be a multidisciplinary approach with the GPs, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, and monitoring for signs of deterioration and, if needed modifications to the medication regimen.